Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Higher basal metabolic rate increases the risk of non-alcoholic fatty liver disease, especially in Chinese people, and may require tailored management.

PCOS is a common disorder in women causing symptoms like irregular periods and weight gain, with management possible through lifestyle changes and medication.

Drinking sweetened tea and late bedtimes increase the risk of hair loss in women.

Drinking sweetened tea and poor sleep habits increase the risk of hair loss in women.

Drinking sweetened tea and poor sleep habits may increase the risk of hair loss in women.

Drinking sweetened tea and late bedtimes increase the risk of hair loss in women.

Drinking sweetened tea and poor sleep increase the risk of hair loss in women.

Flavonoids in Iraqi marshland plants have potential health benefits like antioxidant and anti-inflammatory effects.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Men with severe hair loss may have a higher risk of heart disease.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

PCOS management benefits from combining traditional herbs, modern medicine, and lifestyle changes.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.